In addition, the treatment of 84E7 cells (AR-expressing thyroid cancer cells) with dihydrotestosterone (DHT), which is an agonist of AR, resulted in the suppression of PD-L1 expression. This evidence concerns the gene AR and thyroid gland carcinoma.